O. Kanat Et Al. , "Modified Outpatient Dexamethazone, Cytarabine and Cisplatin Regimen May Lead to High Response Rates and Low Toxicity in Lymphoma," MEDICAL PRINCIPLES AND PRACTICE , vol.19, no.5, pp.344-347, 2010
Kanat, O. Et Al. 2010. Modified Outpatient Dexamethazone, Cytarabine and Cisplatin Regimen May Lead to High Response Rates and Low Toxicity in Lymphoma. MEDICAL PRINCIPLES AND PRACTICE , vol.19, no.5 , 344-347.
Kanat, O., Ozet, A., Ataergin, S., Arpaci, F., Kuzhan, O., Komurcu, S., ... Ozturk, B.(2010). Modified Outpatient Dexamethazone, Cytarabine and Cisplatin Regimen May Lead to High Response Rates and Low Toxicity in Lymphoma. MEDICAL PRINCIPLES AND PRACTICE , vol.19, no.5, 344-347.
Kanat, Ozkan Et Al. "Modified Outpatient Dexamethazone, Cytarabine and Cisplatin Regimen May Lead to High Response Rates and Low Toxicity in Lymphoma," MEDICAL PRINCIPLES AND PRACTICE , vol.19, no.5, 344-347, 2010
Kanat, Ozkan Et Al. "Modified Outpatient Dexamethazone, Cytarabine and Cisplatin Regimen May Lead to High Response Rates and Low Toxicity in Lymphoma." MEDICAL PRINCIPLES AND PRACTICE , vol.19, no.5, pp.344-347, 2010
Kanat, O. Et Al. (2010) . "Modified Outpatient Dexamethazone, Cytarabine and Cisplatin Regimen May Lead to High Response Rates and Low Toxicity in Lymphoma." MEDICAL PRINCIPLES AND PRACTICE , vol.19, no.5, pp.344-347.
@article{article, author={Ozkan Kanat Et Al. }, title={Modified Outpatient Dexamethazone, Cytarabine and Cisplatin Regimen May Lead to High Response Rates and Low Toxicity in Lymphoma}, journal={MEDICAL PRINCIPLES AND PRACTICE}, year=2010, pages={344-347} }